BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3719548)

  • 1. Clinical implications of oncogene activation in human neuroblastomas.
    Brodeur GM; Seeger RC; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    Cancer; 1986 Jul; 58(2 Suppl):541-5. PubMed ID: 3719548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.
    Tsuda T; Obara M; Hirano H; Gotoh S; Kubomura S; Higashi K; Kuroiwa A; Nakagawara A; Nagahara N; Shimizu K
    Cancer; 1987 Aug; 60(4):820-6. PubMed ID: 3594401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
    Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
    Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator.
    Nakagawara A; Ikeda K; Tsuda T; Higashi K; Okabe T
    J Pediatr Surg; 1987 May; 22(5):415-8. PubMed ID: 3585663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
    Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
    Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-myc oncogene amplification and prognostic factors of neuroblastoma in children.
    Nakagawara A; Ikeda K; Tsuda T; Higashi K
    J Pediatr Surg; 1987 Oct; 22(10):895-8. PubMed ID: 3316592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications.
    Brodeur GM; Seeger RC
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):101-11. PubMed ID: 3940169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
    Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
    Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-myc oncogene RNA expression in neuroblastoma.
    Nisen PD; Waber PG; Rich MA; Pierce S; Garvin JR; Gilbert F; Lanzkowsky P
    J Natl Cancer Inst; 1988 Dec; 80(20):1633-7. PubMed ID: 2461451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus.
    Cohn SL; Salwen H; Herst CV; Maurer HS; Nieder ML; Morgan ER; Rosen ST
    Cancer; 1988 Aug; 62(4):723-6. PubMed ID: 3395955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
    Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
    Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-myc amplification in an infant with stage IVS neuroblastoma.
    Cohn SL; Herst CV; Maurer HS; Rosen ST
    J Clin Oncol; 1987 Sep; 5(9):1441-4. PubMed ID: 3625259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
    Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
    J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
    Brodeur GM; Seeger RC; Schwab M; Varmus HE; Bishop JM
    Science; 1984 Jun; 224(4653):1121-4. PubMed ID: 6719137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.